RT Book, Section
A1 Papile, Lu-Ann
A2 Stevenson, David K.
A2 Cohen, Ronald S.
A2 Sunshine, Philip
SR Print(0)
ID 1109791956
T1 Intracranial Hemorrhage
T2 Neonatology: Clinical Practice and Procedures
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071763769
LK accesspediatrics.mhmedical.com/content.aspx?aid=1109791956
RD 2023/03/25
AB Periventricular/intraventricular  hemorrhage  (P/IVH)  is  the  most  common  intracranial  hemorrhage  in  premature  infants.  In  the  United  States,  approximately  14,000  very  low  birth  weight  (VLBW)  infants  are  diagnosed  with  P/IVH  each  year;  of  these,  approximately  7%  will  develop  posthemorrhagic  hydrocephalus  (PHH).  Numerous  risk  factors  for  developing  P/IVH  have  been  described,  most  of  which  are  associated  with  premature  birth.  Because  the  majority  of  babies  with  P/IVH  do  not  manifest  clinical  signs,  the  diagnosis  relies  on  screening  with  noninvasive  cranial  imaging.  There  are  no  effective  neonatal  therapies  to  prevent  P/IVH;  however,  antenatal  steroids  (ANSs)  given  to  women  who  are  anticipated  to  deliver  preterm  reduces  the  frequency  and  severity  of  P/IVH  among  their  offspring.  Infants  with  extensive  P/IVH  have  an  increased  risk  of  later  neurodevelopmental  impairment,  whereas  those  with  less-extensive  P/IVH  may  not.